Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Effepharm is a biotechnology company based in Shanghai, China, specializing in the development and manufacture of high-purity nutritional ingredients, most notably Nicotinamide Mononucleotide (NMN) under the brand name Uthever. The company positions itself as a leader in the longevity and anti-aging sector, focusing on large-scale production and clinical validation of its products. Effepharm's Uthever NMN is widely used by supplement brands globally and has been the subject of multi-center clinical trials to evaluate its safety and efficacy in increasing NAD+ levels. Beyond NMN, the company explores other longevity-related compounds and provides comprehensive technical support and quality assurance for its partners in the nutraceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uthever.